NKGen Biotech (NKGN) Competitors $0.02 +0.01 (+81.82%) As of 02:14 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NKGN vs. UPC, REVB, ARTL, DRMA, VRAX, SRNE, GTBP, ADTX, PWUP, and PRFXShould you be buying NKGen Biotech stock or one of its competitors? The main competitors of NKGen Biotech include Universe Pharmaceuticals (UPC), Revelation Biosciences (REVB), Artelo Biosciences (ARTL), Dermata Therapeutics (DRMA), Virax Biolabs Group (VRAX), Sorrento Therapeutics (SRNE), GT Biopharma (GTBP), Aditxt (ADTX), PowerUp Acquisition (PWUP), and PainReform (PRFX). These companies are all part of the "pharmaceutical products" industry. NKGen Biotech vs. Its Competitors Universe Pharmaceuticals Revelation Biosciences Artelo Biosciences Dermata Therapeutics Virax Biolabs Group Sorrento Therapeutics GT Biopharma Aditxt PowerUp Acquisition PainReform Universe Pharmaceuticals (NASDAQ:UPC) and NKGen Biotech (NYSE:NKGN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Which has better valuation and earnings, UPC or NKGN? Universe Pharmaceuticals has higher revenue and earnings than NKGen Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUniverse Pharmaceuticals$19.29M0.14-$8.73MN/AN/ANKGen BiotechN/AN/A-$82.94M-$1.72-0.01 Is UPC or NKGN more profitable? Company Net Margins Return on Equity Return on Assets Universe PharmaceuticalsN/A N/A N/A NKGen Biotech N/A N/A -479.36% Do insiders and institutionals have more ownership in UPC or NKGN? 0.2% of Universe Pharmaceuticals shares are owned by institutional investors. Comparatively, 76.2% of NKGen Biotech shares are owned by institutional investors. 57.4% of Universe Pharmaceuticals shares are owned by company insiders. Comparatively, 10.4% of NKGen Biotech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer UPC or NKGN? In the previous week, Universe Pharmaceuticals' average media sentiment score of 0.00 equaled NKGen Biotech'saverage media sentiment score. Company Overall Sentiment Universe Pharmaceuticals Neutral NKGen Biotech Neutral Which has more volatility & risk, UPC or NKGN? Universe Pharmaceuticals has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500. Comparatively, NKGen Biotech has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Do analysts prefer UPC or NKGN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Universe Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00NKGen Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryUniverse Pharmaceuticals beats NKGen Biotech on 6 of the 7 factors compared between the two stocks. Get NKGen Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for NKGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NKGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NKGN vs. The Competition Export to ExcelMetricNKGen BiotechBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$2.49M$343.89M$6.22B$21.80BDividend YieldN/AN/A5.74%3.61%P/E Ratio0.00N/A28.6532.41Price / SalesN/A491.64550.7684.89Price / CashN/A22.4437.3824.48Price / Book-0.013.6712.314.59Net Income-$82.94M-$127.22M$3.33B$1.02B7 Day PerformanceN/A-4.58%-1.74%-0.86%1 Month PerformanceN/A5.39%4.72%-0.79%1 Year PerformanceN/A2.64%61.14%10.17% NKGen Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NKGNNKGen BiotechN/A$0.02+81.8%N/A-97.6%$2.49MN/A0.00N/AGap UpUPCUniverse PharmaceuticalsN/A$6.35+5.8%N/AN/A$3.38M$23.02M0.00220Gap DownREVBRevelation Biosciences1.1763 of 5 stars$1.36+1.5%N/A-97.1%$3.13MN/A-0.0210Short Interest ↓ARTLArtelo Biosciences2.211 of 5 stars$4.14+0.2%$24.00+479.7%-53.6%$2.91MN/A-0.225Short Interest ↑DRMADermata Therapeutics1.6964 of 5 stars$4.21-0.2%$10.00+137.5%-73.4%$2.88MN/A-0.268Short Interest ↑VRAXVirax Biolabs Group2.6601 of 5 stars$0.66+1.5%$3.00+354.1%-60.7%$2.83M$6.33K0.005SRNESorrento Therapeutics1.0016 of 5 stars$0.01-9.1%N/A+175.9%$2.76M$60.32M0.00800Gap DownGTBPGT Biopharma2.0038 of 5 stars$0.72-2.4%$11.00+1,427.8%-71.1%$2.62MN/A-0.188Gap DownADTXAditxtN/A$0.48-5.8%N/A-99.9%$2.51M$130K0.0060News CoveragePWUPPowerUp AcquisitionN/A$0.32-4.0%N/A-97.6%$2.46MN/A0.00N/AHigh Trading VolumePRFXPainReform0.9704 of 5 stars$1.27+5.0%N/A-56.8%$2.44MN/A-0.014Gap Up Related Companies and Tools Related Companies Universe Pharmaceuticals Alternatives Revelation Biosciences Alternatives Artelo Biosciences Alternatives Dermata Therapeutics Alternatives Virax Biolabs Group Alternatives Sorrento Therapeutics Alternatives GT Biopharma Alternatives Aditxt Alternatives PowerUp Acquisition Alternatives PainReform Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NKGN) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump cannot stop this trainThe Nobel Committee just confirmed what free-market thinkers have long argued — that true wealth isn’t built t...Porter & Company | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the...Brownstone Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
